17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome

Renato Pasquali; Laura Patton; Patrizia Pocognoli; Graciela Estela Cognigni; Alessandra Gambineri

doi:10.1210/jc.2007-0870

17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2007-0870 ◽

2007 ◽

Vol 92 (11) ◽

pp. 4208-4217 ◽

Cited By ~ 31

Author(s):

Renato Pasquali ◽

Laura Patton ◽

Patrizia Pocognoli ◽

Graciela Estela Cognigni ◽

Alessandra Gambineri

Keyword(s):

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Releasing Hormone ◽

Functional Ovarian Hyperandrogenism ◽

17 Hydroxyprogesterone ◽

Ovarian Hyperandrogenism

Download Full-text

Faculty Opinions recommendation of 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104650.560710 ◽

2008 ◽

Author(s):

David Abbott

Keyword(s):

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Releasing Hormone ◽

Functional Ovarian Hyperandrogenism ◽

17 Hydroxyprogesterone ◽

Ovarian Hyperandrogenism

Download Full-text

Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jcem.81.11.8923867 ◽

1996 ◽

Vol 81 (11) ◽

pp. 4103-4107 ◽

Cited By ~ 2

Author(s):

L Ibañez ◽

J E Hall ◽

N Potau ◽

A Carrascosa ◽

N Prat ◽

...

Keyword(s):

Luteinizing Hormone ◽

Polycystic Ovary Syndrome ◽

Chorionic Gonadotropin ◽

Gnrh Agonist ◽

Human Chorionic Gonadotropin ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Releasing Hormone ◽

17 Hydroxyprogesterone

Download Full-text

Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin- releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.81.11.4103 ◽

1996 ◽

Vol 81 (11) ◽

pp. 4103-4107 ◽

Cited By ~ 23

Author(s):

L. Ibanez

Keyword(s):

Luteinizing Hormone ◽

Polycystic Ovary Syndrome ◽

Chorionic Gonadotropin ◽

Gnrh Agonist ◽

Human Chorionic Gonadotropin ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Releasing Hormone ◽

17 Hydroxyprogesterone

Download Full-text

Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism

Gynecological Endocrinology ◽

10.1080/09513590.2018.1431773 ◽

2018 ◽

Vol 34 (8) ◽

pp. 715-718 ◽

Cited By ~ 2

Author(s):

Wan Yang ◽

Rui Yang ◽

Shuo Yang ◽

Jia Li ◽

Binbin Tu ◽

...

Keyword(s):

In Vitro Fertilization ◽

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Vitro Fertilization ◽

Releasing Hormone ◽

Antagonist Protocol

Download Full-text

Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome

Taiwanese Journal of Obstetrics and Gynecology ◽

10.1016/j.tjog.2019.01.012 ◽

2019 ◽

Vol 58 (2) ◽

pp. 234-238 ◽

Cited By ~ 1

Author(s):

Runa Ozelci ◽

Serdar Dilbaz ◽

Berna Dilbaz ◽

Derya Akdag Cırık ◽

Saynur Yılmaz ◽

...

Keyword(s):

Polycystic Ovary Syndrome ◽

Ovarian Stimulation ◽

Polycystic Ovary ◽

Intrauterine Insemination ◽

Gonadotropin Releasing Hormone ◽

Controlled Ovarian Stimulation ◽

Ovary Syndrome ◽

Releasing Hormone

Download Full-text

Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome

Fertility and Sterility ◽

10.1016/j.fertnstert.2008.11.030 ◽

2010 ◽

Vol 93 (4) ◽

pp. 1179-1184 ◽

Cited By ~ 16

Author(s):

Devrim Ertunc ◽

Ekrem C. Tok ◽

Aysun Savas ◽

Ilay Ozturk ◽

Saffet Dilek

Keyword(s):

Polycystic Ovary Syndrome ◽

Ovarian Stimulation ◽

Polycystic Ovary ◽

Intrauterine Insemination ◽

Gonadotropin Releasing Hormone ◽

Controlled Ovarian Stimulation ◽

Ovary Syndrome ◽

Releasing Hormone

Download Full-text

Early initiation of gonadotropin-releasing hormone antagonist versus long agonist protocols in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection cycles

Evidence Based Womenʼs Health Journal ◽

10.1097/01.ebx.0000481395.18777.90 ◽

2016 ◽

Vol 6 (2) ◽

pp. 68-74

Author(s):

Hamed Youssef ◽

Mahmoud Thabet ◽

Mohamed Emam ◽

Said El Azab ◽

Hesham Al-Inany

Keyword(s):

Polycystic Ovary Syndrome ◽

Intracytoplasmic Sperm Injection ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Early Initiation ◽

Ovary Syndrome ◽

Releasing Hormone

Download Full-text

Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism

Fertility and Sterility ◽

10.1016/s0015-0282(16)56690-4 ◽

1994 ◽

Vol 61 (5) ◽

pp. 817-822 ◽

Cited By ~ 38

Author(s):

Leopoldo Falsetti ◽

Edda Pasinetti

Keyword(s):

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Ovary Syndrome ◽

Releasing Hormone ◽

Idiopathic Hirsutism

Download Full-text

Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist**Supported in part by educational grants from TAP Pharmaceuticals, Deerfield, Illinois (E.A.R.) and Organon, Inc., West Orange, New Jersey (E.A.R.).

Fertility and Sterility ◽

10.1016/s0015-0282(16)58387-3 ◽

1996 ◽

Vol 66 (1) ◽

pp. 54-60 ◽

Cited By ~ 19

Author(s):

Elizabeth A. Ruchhoft ◽

Karen E. Elkind-Hirsch ◽

Russell Malinak

Keyword(s):

New Jersey ◽

Polycystic Ovary Syndrome ◽

Oral Contraceptives ◽

Polycystic Ovary ◽

Gonadotropin Releasing Hormone ◽

Pituitary Function ◽

Ovary Syndrome ◽

Releasing Hormone ◽

Gonadotropin Releasing Hormone Agonist

Download Full-text

The Risk of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome in Patients with Hyperandrogenism

Journal of Pediatric Endocrinology and Metabolism ◽

10.1515/jpem.2003.16.7.1011 ◽

2003 ◽

Vol 16 (7) ◽

Cited By ~ 2

Author(s):

E. Cetinkaya ◽

G. Ocal ◽

M. Berberoğlu ◽

P. Adiyaman

Keyword(s):

Polycystic Ovary Syndrome ◽

Polycystic Ovary ◽

Ovary Syndrome ◽

Functional Ovarian Hyperandrogenism ◽

Ovarian Hyperandrogenism

Download Full-text